Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Camzyos
Biotech
Sanofi scoops up China rights to Cytokinetics’ heart disease med
The rights will be transferred from Corxel, which had offered Cytokinetics up to $200 million in biobucks for regional rights in 2020.
Gabrielle Masson
Dec 20, 2024 11:07am
Edgewise unveils promising early data for heart disease drug
Sep 20, 2024 4:00am
Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos
May 13, 2024 9:36am
